Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1015 of 3330
Next
>>
>
25351 to 25375 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
T47DKBLUC	Unknown	Unknown	Everolimus	MTOR	MTOR	2.67	uM	12608.164	0.7630	0.5655	1.1044
T47DKBLUC	Unknown	Unknown	Everolimus	MTOR	MTOR	13.3	uM	12608.164	0.7803	0.5977	1.1044
T47DKBLUC	Unknown	Unknown	Everolimus	MTOR	MTOR	66.7	uM	12608.164	0.2903	-0.3473	1.1044
UACC-812	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.000171	uM	11938.164	0.9290	0.8031	0.7111
UACC-812	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.000853	uM	11938.164	0.8573	0.6107	0.7111
UACC-812	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.00427	uM	11938.164	0.8836	0.6805	0.7111
UACC-812	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.0213	uM	11938.164	0.8022	0.4669	0.7111
UACC-812	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.107	uM	11938.164	0.7660	0.3748	0.7111
UACC-812	HER2amp	Luminal	Everolimus	MTOR	MTOR	0.533	uM	11938.164	0.7077	0.2300	0.7111
UACC-812	HER2amp	Luminal	Everolimus	MTOR	MTOR	2.67	uM	11938.164	0.6530	0.0984	0.7111
UACC-812	HER2amp	Luminal	Everolimus	MTOR	MTOR	13.3	uM	11938.164	0.7484	0.3305	0.7111
UACC-812	HER2amp	Luminal	Everolimus	MTOR	MTOR	66.7	uM	11938.164	0.5492	-0.1389	0.7111
ZR-75-1	HR+	Luminal	Everolimus	MTOR	MTOR	0.000171	uM	12003.164	0.9684	0.9336	0.9505
ZR-75-1	HR+	Luminal	Everolimus	MTOR	MTOR	0.000853	uM	12003.164	0.9260	0.8447	0.9505
ZR-75-1	HR+	Luminal	Everolimus	MTOR	MTOR	0.00427	uM	12003.164	0.9310	0.8550	0.9505
ZR-75-1	HR+	Luminal	Everolimus	MTOR	MTOR	0.0213	uM	12003.164	0.7415	0.4601	0.9505
ZR-75-1	HR+	Luminal	Everolimus	MTOR	MTOR	0.107	uM	12003.164	0.6361	0.2426	0.9505
ZR-75-1	HR+	Luminal	Everolimus	MTOR	MTOR	0.533	uM	12003.164	0.6082	0.1853	0.9505
ZR-75-1	HR+	Luminal	Everolimus	MTOR	MTOR	2.67	uM	12003.164	0.5451	0.0562	0.9505
ZR-75-1	HR+	Luminal	Everolimus	MTOR	MTOR	13.3	uM	12003.164	0.5374	0.0405	0.9505
ZR-75-1	HR+	Luminal	Everolimus	MTOR	MTOR	66.7	uM	12003.164	0.4545	-0.1277	0.9505
ZR75B	HR+	Luminal	Everolimus	MTOR	MTOR	0.000171	uM	11939.164	1.0044	1.0054	1.6455
ZR75B	HR+	Luminal	Everolimus	MTOR	MTOR	0.000853	uM	11939.164	0.9172	0.8977	1.6455
ZR75B	HR+	Luminal	Everolimus	MTOR	MTOR	0.00427	uM	11939.164	0.8921	0.8659	1.6455
ZR75B	HR+	Luminal	Everolimus	MTOR	MTOR	0.0213	uM	11939.164	0.7647	0.6991	1.6455

|<
<<
Previous
Page 1015 of 3330
Next
>>
>
25351 to 25375 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)